Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Walmart Scrapping Robotic Plans

By John F. Heerdink, Jr.

Reportedly, Walmart Stores, Inc. (WMT) has scrapped plans to use robots to keep track of its inventory and scan shelves. The retailer ended its partnership with Bossa Nova Robotics Inc. dropping its long efforts to automate the task and make the job easier for staff.

The shelf-scanning robots were in use since 2017, in order to digitize processes and help brick-and-mortar stores compete with online retail giants like Amazon and Alibaba.

“This was one idea we tried in roughly 500 stores just as we are trying other ideas in additional stores,” Walmart said in a statement.

Walmart Stores, Inc. (WMT) is a worldwide retailer that operates in various formats. The three segments of the company include Walmart U.S., Walmart International, and Sam’s Club. The company is comprised of discount stores, supermarkets, supercenters, hypermarkets, warehouse clubs, cash and carry stores, home improvement stores, specialty electronics stores, apparel stores, drug stores, convenience stores, and membership-only warehouse clubs; and retail Websites. To learn more about Walmart (WMT) and to continue to track its progress please visit the Vista Partners Walmart Coverage Page

Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives. 

Stay Informed! Stay Competitive! Please join us at Vista Partners and receive our FREE email updates throughout the week and view our exclusive content and research.

Natural Killer (NK) Cell-based Immunotherapy Firm Kiadis Reaches Buyout Agreement With Sanofi (SNY)- Who’s Next?

PROGRESS REPORT: Atossa Therapeutics Completes Enrollment of Phase 1 Clinical Study of AT-301 Nasal Spray Being Developed for the Coronavirus Causing COVID-19

Post View Count : 631
(Read Original Story: Walmart drops plans to use robots for tracking inventory in Reuters)


Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Connect with us